128 related articles for article (PubMed ID: 34195204)
1. The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer.
Tang X; Zhang M; Sun L; Xu F; Peng X; Zhang Y; Deng Y; Wu S
Front Cell Dev Biol; 2021; 9():694652. PubMed ID: 34195204
[TBL] [Abstract][Full Text] [Related]
2. The lncRNAs MIR600HG and TSPOAP1-AS1 may potentially act as biomarkers for predicting pancreatic cancer.
Tian J; Wang Y
Transl Cancer Res; 2020 Feb; 9(2):809-817. PubMed ID: 35117426
[TBL] [Abstract][Full Text] [Related]
3. Identifying the role of hypoxia-related lncRNAs in pancreatic cancer.
Sun J; Zhu S
Genomics; 2023 Sep; 115(5):110665. PubMed ID: 37315872
[TBL] [Abstract][Full Text] [Related]
4. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
Li N; Zhan X
EPMA J; 2020 Jun; 11(2):289-309. PubMed ID: 32549918
[TBL] [Abstract][Full Text] [Related]
5. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
6. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Yin T; Zhao D; Yao S
Front Genet; 2021; 12():679150. PubMed ID: 34163531
[TBL] [Abstract][Full Text] [Related]
8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
11. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
[TBL] [Abstract][Full Text] [Related]
12. Identification of lncRNA
Yang F; Lv SX; Lv L; Liu YH; Dong SY; Yao ZH; Dai XX; Zhang XH; Wang OC
Onco Targets Ther; 2016; 9():7039-7045. PubMed ID: 27895496
[TBL] [Abstract][Full Text] [Related]
13. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
14. Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis.
Li Y; Liang Y; Ma T; Yang Q
Front Oncol; 2020; 10():1092. PubMed ID: 32766141
[No Abstract] [Full Text] [Related]
15. A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.
Zhang H; Zhu M; Du Y; Zhang H; Zhang Q; Liu Q; Huang Z; Zhang L; Li H; Xu L; Zhou X; Zhu W; Shu Y; Liu P
J Cancer; 2019; 10(6):1550-1559. PubMed ID: 31031865
[No Abstract] [Full Text] [Related]
16. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
[TBL] [Abstract][Full Text] [Related]
17. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
[TBL] [Abstract][Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
20. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
